Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A
Portfolio Pulse from
Haemonetics Corporation has completed the sale of its whole blood assets to GVS, S.p.A, including its manufacturing facilities in California and Mexico.
January 14, 2025 | 11:30 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Haemonetics has completed the sale of its whole blood assets to GVS, S.p.A, which includes manufacturing facilities in California and Mexico.
The sale of whole blood assets allows Haemonetics to streamline its operations and focus on its core medical technology solutions. This could lead to improved financial performance and strategic positioning, positively impacting the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100